NDLI: The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies

Content Provider	Springer Nature Link
Author	Mirzaee, Mitra Yaghobi, Ramin Ramzi, Mani Roshan Nia, Mahdi
Copyright Year	2011
Abstract	Acute and chronic viral hepatitis infections are corresponding to increase the risk of different types of hematological malignancies especially with leukemia. In this study the serological and molecular markers of hepatitis viruses were evaluated in patients with different types of leukemia in comparing with control group. In this cross sectional study, 100 EDTA-treated blood samples were collected from leukemia patients and also from healthy control group, respectively. Serological and molecular markers of HBV, HCV and HDV viruses were analyzed for determination of the role of these hepatitis viruses in clinical outcomes of leukemia disorders. Increasing risk factors of leukemia were evaluated statistically in two studied groups by SPSS software. One of molecular and immunological markers of HBV, HDV and HCV was found in 24 of 100 (24%), 22 of 100 (22%), and 1 of 100 (1%) patients with leukemia and in 12 of 100 (12%), 6 of 100 (6%), and 2 of 100 (2%) control patients. Significant differences were detected in detection of HBsAg (P = 0.02), HBeAb (P = 0.009), and HCV-RNA (P = 0.05) between leukemia patients and control group, respectively. The high prevalence of HBV and HCV infective markers were detected in ALL and AML patients. Identification of high prevalence of HBV and HCV infective markers in leukemia patients proposed strong association between hepatitis viral infections and leukemia. Therefore, evaluation of the prevalence of viral hepatitis infections in larger groups of patients with long lasting follow up is suggesting.
Starting Page	1217
Ending Page	1223
Page Count	7
File Format	PDF
ISSN	03014851
Journal	Molecular Biology Reports
Volume Number	39
Issue Number	2
e-ISSN	15734978
Language	English
Publisher	Springer Netherlands
Publisher Date	2011-05-20
Publisher Place	Dordrecht
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	HBV HCV HDV Leukemia Hematological malignancies Animal Biochemistry Animal Anatomy / Morphology / Histology
Content Type	Text
Resource Type	Article
Subject	Genetics Medicine Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients

Prevalence of HBV genotypes among Egyptian hepatitis patients

Prevalence of hepatitis C virus (HCV) genotypes in Balochistan

Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients

TLR3 plays significant roles against hepatitis B virus

The mechanism of acidic hydrolysis of esters explains the HDV ribozyme activity

A shift in the Hepatitis C virus genotype dominance in blood donor samples from Thailand

The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer

Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon

The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies

Similar Documents

Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients

Prevalence of HBV genotypes among Egyptian hepatitis patients

Prevalence of hepatitis C virus (HCV) genotypes in Balochistan

Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients

TLR3 plays significant roles against hepatitis B virus

The mechanism of acidic hydrolysis of esters explains the HDV ribozyme activity

A shift in the Hepatitis C virus genotype dominance in blood donor samples from Thailand

The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer

Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon

The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies